Phibro Animal Health (PAHC) has drawn investor attention after a recent share price move, with the stock closing at $39.44. You might be asking how this current level aligns with its fundamentals. See ...

If you are wondering whether Phibro Animal Health's current share price lines up with its underlying worth, you are not alone ...

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a great ...

TEANECK, N.J.--(BUSINESS WIRE)--(NASDAQ: PAHC) The Food and Drug Administration (FDA), through its Center for Veterinary Medicine (CVM), has taken two actions regarding Mecadox ® (carbadox), a drug ...

Animal health products manufacturer Phibro Animal Health (NASDAQ:PAHC) fell short of the markets revenue expectations in Q1 ...

Recently, Phibro Animal Health CorporationPAHC decided to acquire privately held MVP Laboratories, Inc., an Omaha, NE-based provider of livestock vaccines, vaccine adjuvants and other products, for an ...

Investors have been cautious about medicated feed maker Phibro Animal Health ($PAHC), as concerns about food producers moving away from antibiotics have been on the ...

JPMorgan upgraded Phibro Animal Health Corporation (NASDAQ:PAHC), citing strong execution following its $350 million acquisition of Zoetis' medicated feed additive and water-soluble product portfolio.

Citigroup Inc. is removing one of the irritants in its relationship with the government, its Phibro commodities trading division that is paying one trader an estimated $100 million this year. The deal ...